Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Ointment for Atopic Dermatitis in Pediatric Patients
2016-001160-11Phase 3
- Sponsor
- Roche
- Start
- Sep 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tacrolimus in atopic dermatitis (AD), sponsored by Roche. Primary endpoint: Clinical response by Physician’s Global Assessment.
02
Drugs
tacrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2016-001160-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001160-11.